Sweden · Biotechnology startup
Sweden · Modus Therapeutics
Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.
Funding reportedLast round: Post ipo debt
What company datasets say Modus Therapeutics raised
Funding, as reported
Reported in all190.5Min the source's currency
Rounds4
Last roundPost ipo debt
Last round dateMar 2023
Investors listed6
Founders and team
From Modus Therapeutics's own website: 3 on the team.
- Claes LindbladCFO & Head of IR
- Pernilla SandwallBoard Member | COO of Umecrine Cognition AB
- Sofi ErikssonBoard Member since May 2026.
Biotechnology in Sweden
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Modus Therapeutics in front of investors. Or tell us what we have wrong.